Belatacept for kidney transplant recipients-Reference-Cited by-同舟云学术

Belatacept for kidney transplant recipients

Published:2014-11-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Masson Philip¹,Henderson Lorna²,Chapman Jeremy R³,Craig Jonathan C¹⁴,Webster Angela C¹⁴⁵

Affiliation:

1. The University of Sydney; Sydney School of Public Health; Sydney Australia

2. Royal Infirmary of Edinburgh; Department of Renal Medicine; Edinburgh UK

3. Westmead Millennium Institute, The University of Sydney at Westmead; Centre for Transplant and Renal Research; Darcy Rd Westmead NSW Australia 2145

4. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead NSW Australia 2145

5. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD010699.pub2/fullpdf

Reference268 articles.

1. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study;Bremer;Journal of Translational Medicine,2009

2. 3-year safety profile of belatacept in kidney transplant recipients from the BENEFIT and BENEFIT-EXT studies [abstract no: O-242];Charpentier;Transplant International,2011

3. Long-term exposure to belatacept in recipients of extended criteria donor kidneys;Charpentier;American Journal of Transplantation,2013

4. Charpentier B Vincenti F Rice K Campistol J Duan T Pupim L Three-year outcomes in patients with delayed graft function in phase III studies of belatacept vs cyclosporine in kidney transplantation (BENEFIT and BENEFIT-EXT) [abstract no: PO27.076] 24th International Congress of the Transplantation Society (TTS); 2012 Jul 15-19; Berlin, Germany 2012

5. Health-related quality of life after kidney transplantation: results from belatacept clinical trials [abstract no: 1099];Dobbels;American Journal of Transplantation,2011

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betreuung von Patienten nach Nierentransplantation;Nephrologie aktuell;2024-09

2. Belatacept based immunosuppression: What and when to combine?;Transplant Immunology;2024-08

3. Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry;Transplantation Direct;2024-05-17

4. Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature;Clinics and Practice;2024-05-16

5. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?;Journal of Personalized Medicine;2024-03-20